Literature DB >> 15850745

Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients.

J T Chen1, D L Collins, M S Freedman, H L Atkins, D L Arnold.   

Abstract

Multiple sclerosis (MS) lesions show differing degrees of demyelination and remyelination. Changes in myelin content are associated with changes in magnetization transfer on MRI. Since acute inflammation and demyelination are spatially and temporally inhomogeneous, we hypothesized that local magnetic transfer ratio (MTR) heterogeneity might be predictive of subsequent changes in MTR. To test this hypothesis, we analyzed MTR images obtained in 14 subjects, at baseline and after 2 months follow-up. We segmented lesions and normal-appearing white-matter (NAWM), calculated MTR signal inhomogeneity maps at baseline and MTR lesion difference maps between baseline and follow-up. We found that regions with low MTR inhomogeneity at baseline experienced little further change in MTR on follow-up. The mean change in lesion MTR between baseline and follow-up was 0.10 +/- 3.70; in NAWM it was -0.09 +/- 2.02. We found that regions with high MTR inhomogeneity at baseline would change MTR on follow-up: (1) voxels with significantly high MTR in regions of high MTR inhomogeneity at baseline showed a mean decrease in MTR between baseline and follow-up of -2.51 +/- 4.68 in lesions and -1.41 +/- 3.00 in NAWM; (2) voxels with low MTR in regions of high MTR inhomogeneity at baseline showed a mean increase in MTR between baseline and follow-up of 2.61 +/- 6.07 in lesions. These changes in MTR were significantly different (P < 0.001). These results suggest that calculation of MTR signal inhomogeneity may provide a method for quantifying the potential for remyelination and demyelination, and thus could provide an important MRI biomarker for assessing the efficacy of therapies targeting remyelination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850745     DOI: 10.1016/j.neuroimage.2004.12.046

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  17 in total

1.  Tract-based spatial statistical analysis of diffusion tensor imaging in pediatric patients with mitochondrial disease: widespread reduction in fractional anisotropy of white matter tracts.

Authors:  G E Ishak; A V Poliakov; S L Poliachik; R P Saneto; E J Novotny; S McDaniel; J G Ojemann; D W W Shaw; S D Friedman
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

Review 2.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 3.  A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV.

Authors:  Norman J Haughey; Xiaomao Zhu; Veera Venkata Ratnam Bandaru
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-08       Impact factor: 4.147

Review 4.  Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains.

Authors:  Andrew L Alexander; Samuel A Hurley; Alexey A Samsonov; Nagesh Adluru; Ameer Pasha Hosseinbor; Pouria Mossahebi; Do P M Tromp; Elizabeth Zakszewski; Aaron S Field
Journal:  Brain Connect       Date:  2012-01-27

Review 5.  Remyelinating Pharmacotherapies in Multiple Sclerosis.

Authors:  Riley M Bove; Ari J Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

6.  Neuroradiological evaluation of demyelinating disease.

Authors:  Jan-Mendelt Tillema; Istvan Pirko
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

Review 7.  Diffusion tensor imaging for understanding brain development in early life.

Authors:  Anqi Qiu; Susumu Mori; Michael I Miller
Journal:  Annu Rev Psychol       Date:  2015-01-03       Impact factor: 24.137

8.  Evaluation of normal appearing white matter in multiple sclerosis: comparison of diffusion magnetic resonance, magnetization transfer imaging and multivoxel magnetic resonance spectroscopy findings with expanded disability status scale.

Authors:  Y Anik; A Demirci; H Efendi; S S D Bulut; I Celebi; S Komsuoglu
Journal:  Clin Neuroradiol       Date:  2011-08-17       Impact factor: 3.649

Review 9.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

Review 10.  The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome.

Authors:  Robert Zivadinov; Milena Stosic; Jennifer L Cox; Deepa P Ramasamy; Michael G Dwyer
Journal:  J Neurol       Date:  2008-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.